MeSH tree: D12.776.220.600.450
Around 55 million people worldwide suffer from dementia such as Alzheimer's disease. Recently, the actor Bruce Willis was diagnosed with frontotemporal dementia, or FTD, a rare type of dementia that typically affects people ...
Feb 22, 2023
0
34
Of all the known genetic risk factors for late-onset Alzheimer's disease, the strongest is a gene for the protein called ApoE4. People with one copy of this gene are 3.5 times more likely, on average, to develop Alzheimer's ...
Feb 21, 2023
0
83
Scientists are not yet clear on how the tau protein changes from a benign protein essential for normal function in our brains into the toxic neurofibrillary tangles that are a signature of Alzheimer's and other neurodegenerative ...
Feb 14, 2023
0
65
Many football fans fondly remember Rick Arrington as the Philadelphia Eagles' quarterback from 1970 to 1973, but his daughter's memories are tainted by years spent watching her dad suffer from late-stage chronic traumatic ...
Feb 9, 2023
0
107
University of New Mexico neurologist Rawan Tarawneh, MD, has identified a unique biomarker that could lead to new diagnostic tests to improve the detection of incipient Alzheimer's disease before symptoms appear.
Feb 8, 2023
0
118
A common sign of Alzheimer's disease is the excessive buildup of two types of protein in the brain: tangles of tau proteins that accumulate inside cells, and amyloid-β proteins that form plaques outside the cells. Researchers ...
Feb 2, 2023
0
471
Unintentional weight loss in people with Down syndrome may predict the onset of Alzheimer's disease long before typical cognitive symptoms like memory loss and dementia are apparent.
Jan 31, 2023
0
58
Several progressive neurodegenerative disorders, including Alzheimer's disease, are defined by having tau proteins in the brain. Researchers are seeking to identify the mechanisms behind these tau proteins to develop treatments, ...
Jan 31, 2023
0
100
Researchers may have found an unlikely contributor to the development of Alzheimer's disease: the bacteria in your gut. Their study, published in the journal Science, suggested that certain gut bacteria increase the brain ...
Jan 25, 2023
0
55
The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an "accelerated approval pathway" that fast-tracks promising clinical treatments for diseases ...
Jan 16, 2023
0
52
